Pharma Races to Scale AI as Billions Flow into Drug Discovery - Genetic Engineering and Biotechnology News

Drug companies are investing billions in AI to discover new medicines faster and more efficiently. This could lead to faster development of treatments for diseases, benefiting patients worldwide.